Vascular endothelial cell-targeted mRNA delivery via synthetic lipid nanoparticles for venous thrombosis prevention
Journal of Controlled Release · 2025
DOI: 10.1016/j.jconrel.2025.114147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Zhiwei Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences & Department of Pharmacy, Shanghai Pudong Hospital & State Key Laboratory of Molecular E…. Hauptthemen laut MEDLINE: RNA, Messenger, Venous Thrombosis, Nanoparticles, Lipids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Chinese Academy of Sciences.
Abstract (Originalsprache)
Venous thromboembolism significantly contributes to the global disease burden. Anticoagulant and antiplatelet therapies are currently the treatment strategies. However, challenges remain due to hemorrhagic complications and the inability to resolve established thrombi. There is an urgent need for a new generation of antithrombotic agents. Given the fibrin specificity and rapid thrombus dissolution capacity of recombinant tissue plasminogen activator (TPA) protein, along with the significant advantages of mRNA therapeutics in protein replacement, we aim to develop an antithrombotic strategy through the targeted delivery of TPA mRNA to vascular endothelial cells using synthetic lipid nanoparticles (LNPs). A series of amino ionizable lipids were synthesized to create an LNP library, from which the LNP selectively targeting vascular endothelial cells (vtLNP) was selected by a DNA barcode labeling high-throughput screening method. The antithrombotic efficacy and safety of vtLNP loaded with TPA mRNA (vtLNP@TPA) were evaluated in a deep vein thrombosis (DVT) mouse model and normal ICR mice, respectively. The results revealed that vtLNP@TPA significantly prevented the occurrence and development of venous thrombosis. This study provides relevant experimental evidence for a novel antithrombotic therapy strategy for venous thrombosis using mRNA therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Basic Medical Sciences & Department of Pharmacy, Shanghai Pudong Hospital & State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200030, PR China.
- Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Edu cation, Anhui Medical University, Hefei, Anhui 230032, PR China. Electronic address: fanlf@mail.ustc.edu.cn.
- Institute of Pediatric Translational Medicine, Shanghai Institute for Pediatric Congenital Heart Disease, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, PR China.
- DSciLab Co., Ltd, Wuzhong District, Suzhou, Jiangsu 215100, PR China.
- Department of Pharmacology, School of Basic Medical Sciences & Department of Pharmacy, Shanghai Pudong Hospital & State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200030, PR China; D…
- Department of Pharmacology, School of Basic Medical Sciences & Department of Pharmacy, Shanghai Pudong Hospital & State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200030, PR China. E…
Förderung
- National Natural Science Foundation of China
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Chinese Academy of Sciences
Zitieren
APA
Guo, Z., Fan, L., Ma, Y., Tian, K., Qiu, W., Wei, A., Fu, W., Chen, Y., Cui, Z., Wang, S., & Zhan, C. (2025). Vascular endothelial cell-targeted mRNA delivery via synthetic lipid nanoparticles for venous thrombosis prevention. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.114147
Vancouver
Guo Z, Fan L, Ma Y, Tian K, Qiu W, Wei A, et al. Vascular endothelial cell-targeted mRNA delivery via synthetic lipid nanoparticles for venous thrombosis prevention. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.114147
BibTeX
@article{Guo2025,
author = {Guo, Zhiwei and Fan, Lianfeng and Ma, Yinyu and Tian, Kaisong and Qiu, Wei and Wei, Anqi and Fu, Wei and Chen, Yuanyuan and Cui, Zhiping and Wang, Songli and Zhan, Changyou},
title = {Vascular endothelial cell-targeted mRNA delivery via synthetic lipid nanoparticles for venous thrombosis prevention},
journal = {Journal of Controlled Release},
year = {2025},
doi = {10.1016/j.jconrel.2025.114147}
}
EUVIMED